Clinical Trials Logo

Segmental Overgrowth Syndrome clinical trials

View clinical trials related to Segmental Overgrowth Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT02569125 Withdrawn - Clinical trials for Segmental Overgrowth Syndrome

Open Label Study of Everolimus (RAD001) in Patients With Segmental Overgrowth Syndrome

EPASOS
Start date: January 2016
Phase: Phase 2
Study type: Interventional

This is an open-label, multicenter, single-arm, phase II clinical trial of Everolimus (RAD001) in patients with segmental overgrowth syndrome.